Orbus Therapeutics Appoints Jason Levin, Co-founder and COO to President
PALO ALTO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private, late-stage biopharmaceutical company focused on the...
Brain
Brainomix Partners with Medtronic to Enhance Stroke Care Across Western Europe
OXFORD, England, Feb. 27, 2025 /PRNewswire/ -- Brainomix, a pioneer in stroke AI imaging software and European market leader, has...
FINN Partners and Humble Ventures Expanded ‘Future of Education and Health’ Returns to Austin on Thursday, March 6 – Friday, March 7 at Atelier 1205
Two immersive future-focused days of programming in education and health, bringing together leading innovators, VCs, policymakers, researchers and entrepreneurs for...
Philips accelerates precise imaging with unique AI technologies in MRI to improve patient outcomes
Dual AI engines in SmartSpeed Precise SmartSpeed Precise pelvis clinical image SmartSpeed Precise knee clinical image SmartSpeed Precise sinus clinical...
Eterna Therapeutics Hosts Successful Inaugural Meeting with Newly Formed Scientific Advisory Board to Advance Cell Therapy Pipeline
Meeting addressed progress and strategic direction for company’s induced mesenchymal stem cell (iMSC) therapy programsCAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE...
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
HOUSTON, TX, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader...
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment
SARASOTA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for...
Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
Research Collaboration demonstrates the feasibility of using the LIBERTY® Endovascular Robotic System between separate and remote facilities in a coronary...
Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure...
Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program
BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ -- Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides...
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use
February 24, 2025 Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use Biodexa plans to...
Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health
SARASOTA, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for...
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
Vivos announces immediate expansion of its new alliance model into two additional Colorado locations as initial reports show sleep apnea...
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
Extends cash runway well into mid-2026; no new/replacement warrants issuedKENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc....
NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program
NKGen takes a meaningful step towards potential treatment for frontotemporal dementia (“FTD”) patients with limited treatment options.SANTA ANA, Calif., Feb....
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease
Ex-Takeda VP Tauhid Ali, Ph.D., with broad leadership and drug development experience becomes Board DirectorSeasoned regulatory strategist Darren Rubin becomes...
BioAge Labs to Participate in TD Cowen’s 45th Annual Health Care Conference
RICHMOND, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing...
Arizona Femtech Startup Prickly Pear Health Secures Institutional Pre-Seed Funding, Surpasses Initial Goal of $250K
AI-powered digital health platform addresses cognitive wellness during the menopausal transition, backed by Bayless Ventures and AZ Venture Capital Inc....
Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)
- Chemical process enhances room temperature stability - - Provisional patent applications filed - PURCHASE, N.Y., Feb. 20, 2025 (GLOBE...